Norton Rose, Latham Steer Alcon's $430M Lensar Buy

Eye care company Alcon, advised by Norton Rose Fulbright, unveiled on Monday an agreement to purchase medical technology developer Lensar, which is represented by Latham & Watkins LLP, for up to $430 million....

Already a subscriber? Click here to view full article